HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luis Anibarro Selected Research

Pulmonary Tuberculosis

1/2019High-resolution quantitative proteomics applied to the study of the specific protein signature in the sputum and saliva of active tuberculosis patients and their infected and uninfected contacts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luis Anibarro Research Topics

Disease

8Tuberculosis (Tuberculoses)
12/2021 - 07/2011
8Infections
12/2021 - 05/2010
3Latent Tuberculosis
01/2020 - 09/2011
2Inflammation (Inflammations)
01/2020 - 01/2019
2Meningitis
05/2010 - 05/2010
2Silicosis
05/2010 - 05/2010
1Latent Infection
01/2020
1Pulmonary Tuberculosis
01/2019
1Erythema Induratum (Bazin Disease)
11/2015
1Erythema
08/2012
1Chronic Kidney Failure (Chronic Renal Failure)
08/2012
1Alcoholism (Alcohol Abuse)
01/2004

Drug/Important Bio-Agent (IBA)

8Interferon-gamma (Interferon, gamma)IBA
12/2021 - 05/2010
8Tuberculin (PPD)IBA
01/2018 - 05/2010
4InterferonsIBA
01/2018 - 07/2011
3GoldIBA
12/2021 - 08/2012
2Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2019
2Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2019
2PyrazinamideFDA LinkGeneric
05/2010 - 05/2010
2Ethambutol (Myambutol)FDA LinkGeneric
05/2010 - 05/2010
2Isoniazid (Ftivazide)FDA LinkGeneric
05/2010 - 05/2010
2Rifampin (Rifampicin)FDA LinkGeneric
05/2010 - 05/2010
1AntigensIBA
12/2021
1IronIBA
01/2020
1LipidsIBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1Transferrin (beta 2 Transferrin)IBA
01/2020
1Apoprotein(a) (Apolipoprotein (a))IBA
01/2020
1CarbohydratesIBA
01/2019
1Indicators and Reagents (Reagents)IBA
08/2012
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2011
1Pharmaceutical PreparationsIBA
01/2004

Therapy/Procedure

3Therapeutics
01/2018 - 09/2011